BENEVICH ERIC bought NBIX
January 31, 2026 · Form 4 insider transaction
BENEVICH ERIC bought 2,294 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,294
Price
$0.00
Total value
N/A
InsiderBENEVICH ERIC
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 31, 2026
Filing dateFebruary 3, 2026
Shares owned after54,047
OwnershipDirect
10b5-1 planNo
AmendedNo